-
-
|
97%
|
50mg
|
毕得医药
|
现货
|
¥54
|
|
-
|
97%
|
100mg
|
毕得医药
|
现货
|
¥72
|
|
-
-
|
97%
|
250MG
|
凯为
|
现货
|
¥165
|
|
-
-
|
97%
|
100MG
|
药石科技
|
现货
|
¥330
|
|
-
-
|
97%
|
100MG
|
凯为
|
现货
|
¥410
|
|
-
|
97%
|
250MG
|
药石科技
|
现货
|
¥663
|
|
-
-
-
|
98%
|
250MG
|
凯为
|
现货
|
¥1225
|
|
-
|
97%
|
5G
|
药石科技
|
现货
|
¥2851
|
|
-
|
97%
|
10G
|
药石科技
|
现货
|
¥4745
|
|
-
-
|
97%
|
100MG
|
凯为
|
现货
|
¥68
|
|
-
|
98%
|
100mg
|
毕得医药
|
现货
|
¥70
|
|
-
|
97%
|
250MG
|
凯为
|
现货
|
¥106
|
|
-
|
98%
|
250mg
|
毕得医药
|
现货
|
¥109
|
|
-
-
|
97%
|
250mg
|
麦克林
|
现货
|
¥27
|
|
-
|
97%
|
1g
|
麦克林
|
现货
|
¥30
|
|
-
|
97%
|
5g
|
麦克林
|
现货
|
¥119
|
|
-
|
97%
|
25g
|
麦克林
|
现货
|
¥524
|
|
-
-
|
98%
|
100MG
|
凯为
|
现货
|
¥31
|
|
-
|
97%
|
250mg
|
毕得医药
|
现货
|
¥33
|
|
-
|
98%
|
250MG
|
凯为
|
现货
|
¥33
|
|
-
|
98%
|
1G
|
凯为
|
现货
|
¥95
|
|
-
-
|
97%
|
100mg
|
毕得医药
|
现货
|
¥30
|
|
-
|
97%
|
250mg
|
毕得医药
|
现货
|
¥36
|
|
-
-
|
97%
|
5G
|
凯为
|
现货
|
¥314
|
|
-
-
|
97%
|
100mg
|
毕得医药
|
现货
|
¥174
|
|
-
|
97%
|
250mg
|
毕得医药
|
现货
|
¥356
|
|
-
|
97%
|
1g
|
毕得医药
|
现货
|
¥1251
|
|
-
|
97%
|
5g
|
毕得医药
|
现货
|
¥4827
|
|
-
4-[4-氯-1-丁酰基]-A,A-二甲基苯乙酸甲酯
别名: 4-[4-氯-1-丁酰基]-A,A-二甲基苯乙酸甲酯;2-[4-(4-氯-1-丁酰基)苯基]-2-甲基丙酸甲酯;4-[4-氯-1-丁酰基]-ALPHA,ALPHA-二甲基苯乙酸甲酯;4-[4-氯-1-丁酰基]-Α,Α-二甲基苯乙酸甲酯;4-(4-氯-1-丁酰基)-Α,Α-二甲基苯乙酸乙酯;盐酸非索非那定中间体
-
|
98%
|
250MG
|
百灵威
|
现货
|
¥338
|
|
-
|
98%
|
1G
|
百灵威
|
现货
|
¥971
|
|
-
|
98%
|
5G
|
百灵威
|
现货
|
¥2437
|
|
-
-
|
98%
|
250MG
|
凯为
|
现货
|
¥79
|
|
-
|
98%
|
1G
|
凯为
|
现货
|
¥266
|
|
-
|
98%
|
5G
|
凯为
|
现货
|
¥562
|
|